Selection of Germline Genetic Testing Panels in Patients With Cancer: ASCO Guideline Clinical Insights
JCO Oncology Practice · 2024-10 · 20 (10) · 1308-1313
DOI: 10.1200/op.24.00278 ↗Kurz gefasst
Leitlinie in der Zeitschrift JCO Oncology Practice, 2024-10. Verfasst von Charité Ricker und 5 weiteren Autor:innen. Beteiligte Einrichtung: Keck School of Medicine of USC, Los Angeles, CA. Hauptthemen laut MEDLINE: Genetic Testing, Neoplasms, Germ-Line Mutation. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 8 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Keck School of Medicine of USC, Los Angeles, CA.
- University of Texas MD Anderson Cancer Center, Houston, TX.
- Simmons Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX.
- University of Michigan Rogel Cancer Center, Ann Arbor, MI.
- American Society of Clinical Oncology, Alexandria, VA.
- Beth Israel Deaconess Medical Center, Sharon, MA.
ORCID-Profile: Banu Arun, Hans Messersmith, Nadine Tung
Zitieren
APA
Ricker, C., Arun, B., Pirzadeh-Miller, S., Stoffel, E. M., Messersmith, H., & Tung, N. (2024). Selection of Germline Genetic Testing Panels in Patients With Cancer: ASCO Guideline Clinical Insights. JCO Oncology Practice, 20(10), 1308-1313. https://doi.org/10.1200/op.24.00278
Vancouver
Ricker C, Arun B, Pirzadeh-Miller S, Stoffel EM, Messersmith H, Tung N. Selection of Germline Genetic Testing Panels in Patients With Cancer: ASCO Guideline Clinical Insights. JCO Oncology Practice. 2024;20(10):1308-1313. doi:10.1200/op.24.00278
BibTeX
@article{Ricker2024,
author = {Ricker, Charité and Arun, Banu and Pirzadeh-Miller, Sara and Stoffel, Elena Martinez and Messersmith, Hans and Tung, Nadine},
title = {Selection of Germline Genetic Testing Panels in Patients With Cancer: ASCO Guideline Clinical Insights},
journal = {JCO Oncology Practice},
year = {2024},
volume = {20},
number = {10},
pages = {1308--1313},
doi = {10.1200/op.24.00278}
}
EUVIMED